Key Words: receptors, dopamine Ⅲ receptors, angiotensin II Ⅲ rats, spontaneously hypertensive Ⅲ normotension Ⅲ kidney S everal cardiovascular diseases, including hypertension, are associated with abnormal regulation of sodium balance. This balance is regulated by natriuretic and antinatriuretic hormones and humoral agents. 1-8 Among the numerous factors involved in this process are angiotensin II and dopamine. During moderate volume expansion, renal dopamine production is increased, and dopamine, via D 1 -like (comprised of D 1 and D 5 subtypes) and D 2 -like receptors (comprised of D 2 , D 3 , and D 4 subtypes), acts to increase sodium excretion. 1, [5] [6] [7] [8] In contrast, during salt deprivation, angiotensin II production is increased, and angiotensin II, via angiotensin II type 1 (AT 1 ) receptors, increases renal sodium transport. [2] [3] [4] Angiotensin II antagonizes the natriuretic response elicited by dopamine, and dopamine opposes angiotensin II-mediated sodium transport in the renal proximal tubules (RPTs). 9,10 Even a small increase in intracellular sodium concentration induces an increase in D 1 receptors and a decrease in AT 1 receptors in renal cell surface membranes. 11 Although the counter-regulation between dopamine and angiotensin II
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everal cardiovascular diseases, including hypertension, are associated with abnormal regulation of sodium balance. This balance is regulated by natriuretic and antinatriuretic hormones and humoral agents. [1] [2] [3] [4] [5] [6] [7] [8] Among the numerous factors involved in this process are angiotensin II and dopamine. During moderate volume expansion, renal dopamine production is increased, and dopamine, via D 1 -like (comprised of D 1 and D 5 subtypes) and D 2 -like receptors (comprised of D 2 , D 3 , and D 4 subtypes), acts to increase sodium excretion. 1, [5] [6] [7] [8] In contrast, during salt deprivation, angiotensin II production is increased, and angiotensin II, via angiotensin II type 1 (AT 1 ) receptors, increases renal sodium transport. [2] [3] [4] Angiotensin II antagonizes the natriuretic response elicited by dopamine, and dopamine opposes angiotensin II-mediated sodium transport in the renal proximal tubules (RPTs). 9, 10 Even a small increase in intracellular sodium concentration induces an increase in D 1 receptors and a decrease in AT 1 receptors in renal cell surface membranes. 11 Although the counter-regulation between dopamine and angiotensin II receptors has been shown primarily in RPTs, these receptors may also interact in other areas in the kidney. 5, [11] [12] [13] In addition to counter-regulation of sodium transport by D 1 -like and AT 1 receptors in RPT cells, they also each interact to regulate expression of the other. 14 -19 AT 1 , D 1 , and D 3 receptors may interact, directly or indirectly, in RPT cells from normotensive Wistar-Kyoto rats (WKY). [15] [16] [17] [18] [19] Activation of D 1 -like or D 3 receptors decreases AT 1 receptor expression in RPT cells from WKY. 15, 17 A physical interaction between the other D 1 -like receptor (ie, D 5 ) and the AT 1 receptor has not been reported, although there is indirect evidence for a negative interaction between D 5 and AT 1 receptors in RPT cells. 15 In that study, we found that a D 1 -like receptor, presumably the D 5 receptor, was capable of decreas-ing AT 1 receptor expression in RPT cells from WKY and spontaneously hypertensive rats (SHR). Therefore, we sought direct evidence of an interaction between the AT 1 receptor and the D 5 receptor in RPT cells and determined whether this interaction is different between WKY and SHR.
Methods

AT 1A Receptor-Deficient Mice
The characteristics and genotyping of mice lacking the AT 1A receptor (AT 1A Ϫ/Ϫ) have been reported. 2, 20, 21 The current studies used second-generation AT 1A Ϫ/Ϫ mice from first-generation heterozygous mice of mixed C57BL/6 and B129 background from the University of Virginia. Gender-matched, wild-type littermates were used as controls (AT 1A ϩ/ϩ). After mice were anesthetized with CO 2 , kidneys were harvested, snap-frozen in liquid nitrogen, stored at Ϫ70°C, and shipped to Georgetown University Medical Center.
Generation of Mice Lacking the D 5 Receptor
The generation of mice lacking the D 5 receptor (D 5 Ϫ/Ϫ) has been reported. 22, 23 These mice developed hypertension after 2 months of age. 23 The current studies used D 5 Ϫ/Ϫ mice generated in a C57BL/6 Taconic background. Gender-matched, nontransgenic littermates were used as controls (D 5 ϩ/ϩ).
Blood Pressure Studies
The rats (Taconic; Germantown, NY) were anesthetized with pentobarbital (50 mg/kg IP) and placed on a heated board to maintain body temperature at 37°C. Catheters were inserted into the femoral vessels and right jugular vein. After stable blood pressures were obtained for Ϸ30 minutes (verifying that the SHR were hypertensive and the WKY were normotensive), kidneys were removed and the rats euthanized (pentobarbital; 100 mg/kg IV). The renal cortices were homogenized in ice-cold lysis buffer (PBS with 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L PMSF, 10 g/mL aprotinin, and 10 g/mL leupeptin), sonicated, kept on ice for 1 hour, and centrifuged at 16 000g for 30 minutes. The supernatants were stored at Ϫ70°C until use for immunoblotting. 15-19,24 -27 All experiments were approved by the Georgetown University animal use and care committee.
Cell Culture
Immortalized RPT cells obtained from 4-to 8-week-old WKY and SHR were cultured at 37°C in 95% air/5% CO 2 atmosphere in DMEM/F-12 culture media. [15] [16] [17] [18] [25] [26] [27] These RPT cells have characteristics similar to freshly obtained RPT brush border membranes and RPTs, at least with regard to D 1 receptors and responses to G-protein stimulation. [25] [26] [27] The cells (80% confluence) were extracted in ice-cold lysis buffer, sonicated, kept on ice for 1 hour, and centrifuged at 16 000g for 30 minutes. The supernatants were stored at Ϫ70°C until use for immunoblotting.
Immunoblotting
AT 1 receptor antibody (Abcam Limited) is a mouse monoclonal antibody; the specificity of this antibody to the AT 1 receptor has been reported. 28 The amino acid sequence of the peptide for the rabbit anti-human D 5 receptor antibody corresponds to the third intracellular loop of the D 5 receptor. We reported the specificity of this D 5 receptor antibody. 29 Rat RPT cells were treated with vehicle (distilled H 2 O), angiotensin II (Peninsula Laboratories) or an AT 1 receptor antagonist (losartan; Merck) at the indicated concentrations and times. 30 Immunoblotting was performed as reported previously, except that the transblots were probed with the D 5 (1:500) or the AT 1 receptor antibody (1:400). 15-19,24 -27,29 The blots were scanned and the densities expressed as percent area, with the total area in a particular group set at 100%. 15-18,24 -27,29 When appropriate, the densities of the receptor bands were corrected by the density of the ␣-actin band.
Confocal Microscopy of Double-Stained RPT Cells
RPT cells, grown on coverslips, were fixed and permeabilized with 100% methanol (30 minutes). The D 5 receptor was visualized using a rabbit anti-human D 5 receptor antibody followed by a fluorescein isothiocyanate (FITC)-conjugated anti-rabbit secondary antibody (Molecular Probes) or by a mouse anti-AT 1 receptor monoclonal antibody (Abcam Limited), followed by an Alexa Fluor 568 -goat anti-mouse IgG antibody (Molecular Probes). Cells on coverslips were mounted with the ProLong Antifade Kit (Molecular Probes). Negative controls included absence of primary or secondary antibodies. Immunofluorescence densities and images were acquired (Olympus AX70) at an excitation wavelength of 488 and 568 nm; emission was detected at 535 and 645 nm. 29 
Statistical Analysis
Data are expressed as meanϮSEM. Comparison within groups was made by ANOVA for repeated measures (or paired t test when only 2 groups were compared), and comparison among groups (or t test when only 2 groups were compared) was made by ANOVA with Holm-Sidak test. A value of PϽ0.05 was considered significant.
Results
AT 1 Receptors Decrease D 5 Receptor Expression in RPT Cells From SHR and WKY
Angiotensin II decreased D 5 receptors in a concentration-and time-dependent manner in RPT cells from WKY. The maximum inhibitory effect was 43%; it was significant at and Ͼ10 Ϫ8 M; the concentration for half-maximal inhibition was 2.7ϫ10 Ϫ9 M ( Figure 1A ). The inhibitory effect of angiotensin II (10 Ϫ8 M) was noted as early as 8 hours and maintained for Ն30 hours (t 1/2 ϭ4.9 hours; Figure 1B ).
The specificity of angiotensin II as an AT 1 receptor agonist was also determined by studying the effect of the AT 1 receptor antagonist losartan. Consistent with the study shown in Figure 1A and 1B, angiotensin II (10 Ϫ8 M/24 hours), decreased D 5 receptors in WKY cells (control 1.10Ϯ0.06; angiotensin II 0.76Ϯ0.06; nϭ7; PϽ0.05). The AT 1 receptor antagonist losartan (10 Ϫ8 M/24 hours), by itself, had no effect on D 5 receptor expression (1.04Ϯ0.06) but reversed the inhibitory effect of angiotensin II on D 5 receptor expression (1.10Ϯ0.06; Figure 1C ).
We next compared the effect of angiotensin II on D 5 receptor expression studied concurrently in RPT cells from WKY and SHR. In RPT cells from WKY and SHR, angiotensin II (10 Ϫ8 M/24 hours) also decreased D 5 expression (WKY 1.44Ϯ0.07 versus 0.92Ϯ0.08; SHR 0.96Ϯ0.08 versus 0.72Ϯ0.08; nϭ12), and the degree of reduction in SHR (28Ϯ7%) was similar to that noted in WKY cells (35Ϯ6%; Figure 1D ).
Basal D 5 receptor levels were lower in SHR than in WKY RPT cells (0.96Ϯ0.08 versus 1.44Ϯ0.07; nϭ12; Figure 1D ). D 5 receptor protein was also decreased in brush border membranes from the kidney of SHR compared with WKY (WKY 1.46Ϯ0.16 versus SHR 0.54Ϯ0.10; nϭ5; PϽ0.01; Figure 1E ).
Angiotensin II Decreases AT 1 Receptor Expression in RPT Cells From WKY But Increases It in SHR
To confirm our previous report on the effect of angiotensin II on AT 1 receptor expression in RPT cells, 16 we used a different monoclonal AT 1 antibody in this study. RPT cells were incubated with angiotensin II for the indicated times and concentrations. Angiotensin II decreased AT 1 receptor expression in a concentration-and time-dependent manner in RPT cells from WKY (EC 50 ϭ6.6ϫ10 Ϫ8 M; t 1/2 ϭ4.2 hours; Figure 2A and 2B). Whereas angiotensin II decreased its own receptor expression in RPT cells from WKY, it increased it in RPT cells from SHR (WKY 1.00Ϯ0.04 versus 0.72Ϯ0.08; SHR 0.96Ϯ0.04 versus 1.32Ϯ0.08; nϭ8; PϽ0.05; Figure  2C ), in agreement with our previous report. 16 
AT 1 Receptor Colocalizes With the D 5 Receptor in Rat RPT Cells
To determine the potential for a direct or indirect interaction between D 5 and AT 1 receptors, we studied the colocalization of D 5 and AT 1 receptors in RPT cells from WKY. D 5 and AT 1 receptors were found throughout the cell, with evidence of colocalization, especially at the cell surface membrane (Figure 3) . To determine whether there is a physical interaction 
AT 1 Receptor Expression Is Increased in the Kidneys of D 5 ؊/؊ Mice
We next determined whether the D 5 receptor could regulate AT 1 receptor expression in vivo. We found that F6 pentobarbital-anesthetized congenic D 5 Ϫ/Ϫ mice (F6) had higher systolic blood pressure (SBP) and diastolic blood pressure (DBP; SBP 117Ϯ5 mm Hg; DBP 85Ϯ2 mm Hg; nϭ5) than wild-type C57BL/6 (Taconic) mice (SBP 94Ϯ2 mm Hg; DBP 69Ϯ3 mm Hg; nϭ5; PϽ0.05; t test), in agreement with previous reports. 23, 31 The arterial blood pressures of awake D 5 Ϫ/Ϫ mice were in the hypertensive range. 23 
Discussion
Alterations in the responsiveness of the proximal tubule to angiotensin II and dopamine have important implications for net sodium reabsorption. Several studies have shown that the dopaminergic and renin-angiotensin systems interact to regulate renal function. 9 -11,15,16 For example, inhibition of renal angiotensin II production or blockade of AT 1 receptors increases the natriuretic effect of the D 1 -like agonist fenoldopam. 9,32 D 1 -like and D 2 -like receptor agonists also antagonize the stimulatory effect of angiotensin II, acting via AT 1 receptors, on renal proximal tubular luminal sodium transport. 10, 33, 34 The renal vasoconstrictor effect of angiotensin II can also be antagonized by D 1 -like receptor agonists, 35 and angiotensin-converting enzyme inhibition augments the renal vasodilator effect of a D 1 -like receptor agonist. 36 Our previous studies showed that dopamine, via D 1 -like and D 3 receptors, inhibits AT 1 receptor expression; 15, 17 indirect evidence suggests that the D 5 receptor may be involved in the inhibitory effects of a D 1 -like receptor on AT 1 receptor. 15 This is consistent with our finding in human RPT cells indicating that the D 5 but not the D 1 receptor decreases AT 1 receptor expression, 37 and AT 1 receptor expression in renal cortical membrane of D 5 Ϫ/Ϫ mice is increased relative to wild-type littermates.
To better understand the interaction between dopamine and AT 1 receptors, we investigated the effect of AT 1 receptor activation on the expression of dopamine receptor subtypes in RPT cells. In a preliminary communication, we reported that activation of the AT 1 receptor increases D 1 receptor expression in RPT cells from WKY but not from SHR. 18 The ability of dopamine and D 1 -like agonists to couple to signal transducers and decrease renal proximal tubular sodium reabsorption is impaired in genetic rodent hypertension and human essential hypertension. 1, 5, 7, 8, 26, 38 Indeed, the aberrant D 1 -like receptor function in the kidney precedes and cosegregates with high blood pressure in SHR. 1, 5, 7, 8 In addition, disruption of the D 1 or D 5 receptor in mice produces hypertension. 23, 31, 39 Although total cellular D 1 receptor expression is not different in RPT cells of WKY and SHR, D 1 -like receptor-mediated natriuresis is impaired in SHR because of an uncoupling of D 1 -like receptors from their G-protein/effector enzyme complex. 1, 5, 7, 8, 26 In this study, we find that D 5 receptor expression is decreased in RPT cell and renal brush border membranes from SHR compared with WKY cells. Because the increase in cAMP levels after D 1 -like receptor stimulation is attributable mainly to the D 1 receptor relative to the D 5 receptor, 40 we speculate that the effect of AT 1 receptors on D 5 receptor expression may not have as significant an impact on renal tubular function relative to the effect of the AT 1 receptor on the D 1 receptor. However, the ability of the D 5 receptor to negatively regulate the AT 1 receptor may have a significant impact on the regulation of blood pressure. Indeed, in the current report, we show that renal D 5 receptor protein is increased in AT 1A receptor-deficient mice, and renal AT 1 receptor is increased in D 5 receptor-deficient mice, relative to their wild-type littermates.
The role of this differential expression of D 5 receptors on renal sodium handling remains to be determined. However, the hypertension in D 5 Ϫ/Ϫ mice is aggravated by increased sodium intake. 41 We speculate that this may be, in part, attributable to increased renal expression of AT 1 The mechanism for the decrease in D 5 receptor caused by AT 1 receptors was not studied. We find colocalization of D 5 and AT 1 receptors in RPT cells. However, there is no physical interaction determined by coimmunoprecipitation study, which indicates that D 5 and AT 1 receptors interact with each other via an indirect pathway. We have reported in a preliminary communication that the D 5 receptor decreases AT 1 receptor expression by increasing its degradation in human RPT cells. 37 It is possible that the AT 1 receptor regulates D 5 receptor expression by similar mechanisms.
The effect of angiotensin II on AT 1 receptor expression in RPT cells has not been consistent. In rabbit RPT cells, a 16-hour incubation with angiotensin II dose-dependently increases AT 1 receptor expression, assessed by radioligand binding. 42 AT 1 receptor mRNAs in rat and rabbit RPT cells are also increased by angiotensin II. 43, 44 However, the intravenous administration of angiotensin II that increases systemic blood pressure does not alter immunoreactive renal AT 1 receptor expression but decreases AT 1 receptor expression (radioligand autoradiography) in glomeruli and inner stripe of the outer medulla. Three days after the infusion of angiotensin II, there is a tendency for a decrease in AT 1 expression in the whole kidney and in RPTs, but the changes are modest and do not reach statistical significance. 44 We reported that angiotensin II decreases AT 1 receptor, determined by immunoblotting, in cells from WKY. 16 Because the specificity of commercially available antibodies has been questioned, the current studies used a different AT 1 receptor antibody. Using a monoclonal AT 1 receptor antibody, we again find that angiotensin II decreases AT 1 expression in RPT cells from WKY but produces the opposite effect in SHR. This contrasting effect of angiotensin II on AT 1 receptor expression in WKY and SHR suggests that our findings cannot be explained by limitations of AT 1 receptor antibodies. Rather, the strain-specific effect of angiotensin II on AT 1 receptor may be important in the pathogenesis of hypertension in SHR. However, it is realized that the renal expression of AT 1 receptors in SHR has not been consistently shown to be elevated. [45] [46] [47] [48] [49] [50] [51] [52] For example, ovariectomy or salt loading in SHR increases renal AT 1 receptors. 44, 45 However, renal outer medullary but not cortical AT 1 expression has been reported to be increased in SHR relative to WKY. 47, 48 An autoradiographic study showed increased angiotensin II binding in all areas of the kidney of SHR (relative to WKY) at 1 week of age. 49 Renal cortical and brush border membrane AT 1 receptor binding is also higher in 4-week-old SHR relative to WKY. 50 AT 1 receptor expression is higher in certain cerebral nuclei and arteries of adult SHR relative to WKY. 51, 52 We also find no difference in AT 1 receptor protein in RPT cells from WKY and SHR. In contrast, AT 1 receptor expression in brush border membranes is higher in SHR than in WKY. 53 It is possible that discrepancies in published studies may be related to differences in membrane preparation.
In summary, we have demonstrated that activation (constitutively or via their respective ligands) of D 5 and AT 1 receptors negatively regulates the expression of each other. Taken together with our previous studies on the negative interaction between D 1 /D 3 receptors on the one hand and AT 1 receptors on the other, dopamine receptors and AT 1 receptors may counter-regulate each other. Such a counter-regulation may have important implications in the regulation of sodium excretion and blood pressure.
Perspectives
Dopamine, mainly via D 1 -like receptor (D 1 and D 5 ), increases sodium excretion by inhibition of NHE3, Na ϩ -K ϩ ATPase, Cl Ϫ /HCO 3 Ϫ , and Na ϩ /HCO 3 Ϫ exchanger activities. Conversely, angiotensin II, via AT 1 receptor, decreases sodium excretion by stimulation of renal tubular ion transport. [1] [2] [3] [4] [5] [6] [7] [8] Whereas there is reciprocal dopamine and angiotensin modulation in WKY, this effect is altered in SHR. The faulty D 1 receptor cannot counter the effects of AT 1 receptors in SHR, and the negative modulating action of angiotensin II on AT 1 receptors in WKY is actually reversed in SHR. The net result is enhanced antinatriuresis. Although the D 5 receptor contin-ues to be a negative regulator of AT 1 in SHR, the decreased expression of D 5 receptors compared with WKYs may limit its effectiveness. Transregulation at the protein level, by alterations in protein synthesis or degradation, 37 is a mechanism by which these receptors regulate each other.
